| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Ceftriaxone (as ceftriaxone sodium) 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Aldesleukin 18megaunits powder for injection solution vial |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Methylprednisolone sodium succinate 2g powder for injection solution vial |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Anidulafungin 100mg powder for injection solution vial |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| immunoglobuline humaine G, flacon de 2,5 g d'une poudre pour solution injectable |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Decitabine 50 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Spectinomycin 2g powder for injection solution vial |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Romiplostim 500 microgram powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Varicella-zoster virus antibody 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely idarubicin hydrochloride 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| immunoglobuline humaine G, flacon de 5 g d'une poudre pour solution injectable |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| C1 esterase inhibitor 500 units powder for injection solution 8mL vial |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Bacitracin 50,000units powder for injection solution vial |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Rubella immunoglobulin 25,000iu powder for injection solution vial |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Agalsidase beta 35 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Follitropin alfa 150u powder for injection solution ampule |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely somatrem 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely recombinant human antithrombin III 1750 international unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely thiopental sodium 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Somatrem 10 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Thiothixene hydrochloride 5mg powder for injection solution vial |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Streptozocin 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Siltuximab 100 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Siltuximab 400 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely dalbavancin (as dalbavancin hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Tedizolid phosphate 200 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Belinostat 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Porfimer sodium 15 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely porfimer sodium 75 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| hydralazine hydrochloride 20 mg, fiole de poudre pour injection |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Diamorphine hydrochloride 10 mg powder for solution for injection ampule |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely diamorphine hydrochloride 30 milligram/1 ampule powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Diamorphine hydrochloride 100 mg powder for solution for injection ampule |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely diamorphine hydrochloride 500 milligram/1 ampule powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Botulinum toxin type A 500 unit powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely benzylpenicillin sodium 1.2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Benzylpenicillin sodium 600 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Amoxicillin (as amoxicillin sodium) 250 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Amoxicillin (as amoxicillin sodium) 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Cefotaxime (as cefotaxime sodium) 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cefotaxime (as cefotaxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cefoxitin (as cefoxitin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| ceftazidime 500 mg, pour injection (poudre pour reconstitution) |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| ceftazidime 1 g, pour injection (poudre pour reconstitution) |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| ceftazidime 2 g, pour injection (poudre pour reconstitution) |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cefradine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Cefradine 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Colistimethate sodium 500000 unit powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely colistimethate sodium 1 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Somatropin 12 mg powder for solution for injection cartridge |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Ifosfamide 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Ifosfamide 2 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Treosulfan 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Doxorubicin hydrochloride 10 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Epirubicin hydrochloride 10 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Epirubicin hydrochloride 20 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely epirubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Mitomycin 20 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Etoposide (as etoposide phosphate) 100 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely vindesine sulfate 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely indometacin (as indometacin sodium trihydrate) 1 milligram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Dantrolene sodium 20 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Dolasetron mesilate 20 mg powder for solution for injection ampoule |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely hemin 313 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely sargramostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Canakinumab 150mg powder for injection solution |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Temsirolimus 25mg/mL powder for conventional release solution for injection vial |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely somatropin(rbe) 12 milligram/1 cartridge powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Epoetin beta 10,000iu powder for conventional release solution for injection cartridge |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Factor VIII 500iu/von Willebrand factor 1100iu powder for conventional release solution for injection vial |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely peginterferon alfa-2b 100 microgram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely somatropin(rmc) 3.33 milligram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely acetazolamide 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Thymosin alpha 1 1.6mg powder for conventional release solution for injection vial |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Epoetin beta 100,000iu powder for conventional release solution for injection vial |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely melphalan (as melphalan hydrochloride) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely somatropin(rmc) 1.33 milligram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely albiglutide 30 milligram/1 pen powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Treosulfan 5 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Epoetin beta 20,000iu powder for conventional release solution for injection cartridge |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely alteplase 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely peginterferon alfa-2b 150 microgram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely ixabepilone 45 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely teicoplanin 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Albiglutide 50 mg powder for solution for injection pen |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Disodium pamidronate 30 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Epoetin beta 50,000iu powder for conventional release solution for injection vial |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely peginterferon alfa-2b 50 microgram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely teicoplanin 400 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely alteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Vinblastine sulfate 10 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Epoetin beta 60,000iu powder for conventional release solution for injection cartridge |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely peginterferon alfa-2b 80 microgram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely tenecteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|